Atopic Dermatitis Beyond Cutaneous Inflammation: The Interplay Between Progesterone, Testosterone, Gut Microbiota, and Immune Dysregulation
Authors:
- Patricia Guevara-RamírezPGPatricia Guevara-Ramírez
- Elius Paz-CruzEPElius Paz-Cruz
- Viviana A. Ruiz-PozoVRViviana A. Ruiz-Pozo
- Santiago Cadena-UllauriSCSantiago Cadena-Ullauri
- Rafael Tamayo-TrujilloRTRafael Tamayo-Trujillo
- Andrés CadenaACAndrés Cadena
- Nicole Hannah JaramilloNJNicole Hannah Jaramillo
- Luci Hidalgo MeloLMLuci Hidalgo Melo
- Ana Karina ZambranoAZAna Karina Zambrano
Open Access
- 17 July 2026
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1565
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by epithelial barrier dysfunction, immune dysregulation, and marked clinical heterogeneity. Although sex hormones and gut microbiota have independently been implicated in AD, their potential interactions remain incompletely understood. This narrative review integrates evidence from clinical, experimental, and preclinical studies examining the interplay among progesterone, testosterone, gut microbiota, and AD, with emphasis on immune regulation, epithelial barrier function, and gut–skin communication. Overall, the available evidence suggests that progesterone is predominantly associated with type 2 immune responses, alterations in epithelial barrier homeostasis, and context-dependent microbial remodeling. In contrast, physiological testosterone is generally associated with immunoregulatory effects and microbial profiles enriched in short-chain fatty acid-producing bacteria, whereas local androgen metabolism may contribute to skin barrier dysfunction. Current evidence also supports a bidirectional relationship between gut microbiota and sex hormones, whereby hormonal fluctuations influence microbial composition while microbial metabolism may modify steroid hormone bioavailability. Collectively, these findings support an integrated endocrine–microbial–immune framework that may contribute to AD beyond cutaneous inflammation. Although direct evidence simultaneously evaluating these components remains limited, this framework may help explain sex-specific differences in disease susceptibility, severity, and clinical course while guiding future mechanistic studies of the hormone–gut microbiota–skin axis.Keywords
Funding Information
- universidad ute
This publication has 94 references indexed in Scilit:
- Gut bacteria metabolize natural and synthetic steroid hormones via the reductive OsrABC pathwayCell Host & Microbe, 2025
- Current updates in the epidemiology and comorbidities of atopic dermatitisAnnals of Allergy, Asthma & Immunology, 2025
- Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe AsthmaClinical Reviews in Allergy & Immunology, 2025
- The estrobolome: Estrogen‐metabolizing pathways of the gut microbiome and their relation to breast cancerInternational Journal of Cancer, 2025
- Prevalence of sleep disorders in atopic dermatitis: a systematic review and meta-analysisArchives of Dermatological Research, 2025
- Global Burden of Atopic DermatitisDermatologic Clinics, 2024
- Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic DermatitisDermatology and Therapy, 2022
- Relationship between gut microbiota and host-metabolism: Emphasis on hormones related to reproductive functionAnimal Nutrition, 2021
- Progesterone Increases Bifidobacterium Relative Abundance during Late PregnancyCell Reports, 2019
- Autoimmune progesterone dermatitis: Update and insightsAutoimmunity Reviews, 2016